Last updated on November 2018

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Brief description of study

The aim of the study is to evaluate efficacy and safety of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with preserved ejection fraction

Clinical Study Identifier: NCT03057951

Contact Investigators or Research Sites near you

Start Over

Domingo Pascual Figal

Hospital Universitario Virgen de la Arrixaca
El Palmar, Spain
  Connect »